Disease/Infection News

RSS

Researchers present a novel genomic sequence data-based mathematical framework for rapid detection of SARS-CoV-2 variants

Researchers presented a novel genomic sequence data-based mathematical framework for rapid detection of SARS-CoV-2 variants of interest and variants of concern in a viral multiple sequence alignment.

28 Jul 2022

The kinetics of SARS-CoV-2 nucleocapsid antibodies up to 21 months after infection

Researchers found significant seroreversion of total anti-nucleocapsid immunoglobulin.

28 Jul 2022

Years of life lost associated with leading causes of US death during the first 20 months of the COVID-19 pandemic

Researchers estimated the years of life lost during the COVID-19 pandemic in the United States.

28 Jul 2022

New COVID vaccine patch could better fight variants than a traditional needle, finds study

A needle-free vaccine patch could better fight COVID-19 variants, such as Omicron and Delta, than a traditional needle vaccine according to a University of Queensland study in mice.

28 Jul 2022

Face shields fail to provide high level of protection against COVID-19, finds study

If you wore a face shield during the pandemic, it probably didn't give you a high level of protection against Covid, according to new research from the University of East Anglia.

28 Jul 2022

Study finds molnupiravir well-tolerated, and effective in vaccinated and unvaccinated

Researchers report the phase II efficacy and safety of molnupiravir in both unvaccinated and vaccinated individuals.

27 Jul 2022

Icelandic study reveals how many children experience severe COVID symptoms

Researchers explore the incidence of SARS-CoV-2 infections in Icelandic children.

27 Jul 2022

Efficacy of COVID mRNA vaccines among patients on CAR‐T‐lymphocyte therapy

Researchers evaluate the effectiveness of mRNA COVID-19 vaccines among patients receiving CAR‐T‐lymphocyte therapy.

27 Jul 2022

Efficacy of monoclonal antibodies against Omicron BA.1, BA.2, and BA.5

Researchers evaluate the neutralizing potency of therapeutic monoclonal antibodies against three sub-lineages of the SARS-CoV-2 Omicron variant.

27 Jul 2022

A comparison of SARS-CoV-2 antibody profiles in elderly and younger individuals

Researchers evaluate antibody titers after double COVID-19 vaccination among very elderly individuals over the age of 90 and a younger population.

27 Jul 2022

Highly specialized T cells remain in blood 20 months after COVID-19

researchers analyze T-cell reactivity following recovery from COVID-19.

27 Jul 2022

The nose key to winning the war against COVID-19

researchers assess the respiratory mucosal immunity elicited by COVID-19 vaccination.

27 Jul 2022

CDC investigation notice highlights outbreak of Salmonella infections from small turtles purchased online

A CDC investigation notice regarding a multistate outbreak of Salmonella infections has been posted: https://www.cdc.gov/salmonella/stanley-07-22/index.html

27 Jul 2022

Specific area of SARS-CoV-2 spike protein found to be a promising target for pan-coronavirus vaccine

Researchers at the Francis Crick Institute have shown that a specific area of the SARS-CoV-2 spike protein is a promising target for a pan-coronavirus vaccine that could offer some protection against new virus variants, common colds, and help prepare for future pandemics.

27 Jul 2022

Study finds specific molecular barriers to SARS-CoV-2 replication in bat cells

Bat cells have specific molecular barriers to deal with SARS-CoV-2 replication, according to a study published in Journal of Virology —publication of the American Society of Microbiology— which includes the participation of Jordi Serra-Cobo, lecturer of the Faculty of Biology and the Biodiversity Research Institute (IRBio) of the University of Barcelona and expert on ecoepidemiological studies.

27 Jul 2022

Investigating an effective linear deoxyribonucleic acid COVID-19 vaccine option for domestic cats

In a new study, investigators studied a linear deoxyribonucleic acid (linDNA) SARS-CoV-2 vaccine option in felines.

27 Jul 2022

Increased resistance to human interferons could be a potential driver of SARS-CoV-2 evolution

Researchers compared the potency of 17 human interferons (IFNs) against multiple SARS-CoV-2 variants.

27 Jul 2022

Study shows SARS-CoV-2 impairs interferon production through NSP2-induced repression of mRNA translation

Researchers discovered a SARS-CoV-2 non-structural protein 2 (NSP2)-mediated mechanism by which it suppresses the production of interferon-beta (IFN-β) in host cells.

27 Jul 2022

Scientists receive $3.9 million NIH grant to eradicate HIV from the brain

Finding a cure for HIV has been extremely difficult, in part because the virus hides from antiretroviral treatments in one of the hardest places to reach: the brain.

27 Jul 2022

Innovative technology reveals new insights into cellular reservoirs of HIV

In a presentation today at AIDS 2022, the 24th International AIDS Conference in Montreal, scientists with the National Institute of Allergy and Infectious Diseases' (NIAID) Vaccine Research Center (VRC) and their collaborators described how their use of cutting-edge technology revealed new insights into cellular reservoirs of HIV and what those observations could mean for the next steps in HIV cure research. NIAID is part of the National Institutes of Health.

27 Jul 2022

Disease/Infection News

Researchers present a novel genomic sequence data-based mathematical framework for rapid detection of SARS-CoV-2 variants

The kinetics of SARS-CoV-2 nucleocapsid antibodies up to 21 months after infection

Years of life lost associated with leading causes of US death during the first 20 months of the COVID-19 pandemic

New COVID vaccine patch could better fight variants than a traditional needle, finds study

Face shields fail to provide high level of protection against COVID-19, finds study

Study finds molnupiravir well-tolerated, and effective in vaccinated and unvaccinated

Icelandic study reveals how many children experience severe COVID symptoms

Efficacy of COVID mRNA vaccines among patients on CAR‐T‐lymphocyte therapy

Efficacy of monoclonal antibodies against Omicron BA.1, BA.2, and BA.5

A comparison of SARS-CoV-2 antibody profiles in elderly and younger individuals

Highly specialized T cells remain in blood 20 months after COVID-19

The nose key to winning the war against COVID-19

CDC investigation notice highlights outbreak of Salmonella infections from small turtles purchased online

Specific area of SARS-CoV-2 spike protein found to be a promising target for pan-coronavirus vaccine

Study finds specific molecular barriers to SARS-CoV-2 replication in bat cells

Investigating an effective linear deoxyribonucleic acid COVID-19 vaccine option for domestic cats

Increased resistance to human interferons could be a potential driver of SARS-CoV-2 evolution

Study shows SARS-CoV-2 impairs interferon production through NSP2-induced repression of mRNA translation

Scientists receive $3.9 million NIH grant to eradicate HIV from the brain

Innovative technology reveals new insights into cellular reservoirs of HIV

Fourier 80: bringing benchtop NMR systems to the laboratory

How industrial hygiene flow calibration supports defensible exposure data

How electrical engineering ensures accurate calibration and patient safety

Latest News